Document is current
Any future updates will be listed below
-
Authors
Weiss, Felix D. https://orcid.org/0000-0003-0228-5081
Alvarez, Yubell
Shakeri, Farhad
Sahu, Anshupa
Leka, Petro
Dernst, Alesja
Rollheiser, Jessika
Vasconcelos, Matilde
Geraci, Adriana
Duthie, Fraser
Stahl, Rainer
Lee, Hye Eun
Gellner, Anne-Kathrin
Buness, Andreas
Latz, Eicke
Meissner, Felix https://orcid.org/0000-0003-1000-7989
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB1454 - 432325352, SFB1402 – 414786233, TRR237 – 369799452, GRK2168 – 272482170, EXC2151 – 390873048, SFB1454 - 432325352)
Helmholtz Association (ZT-0027)
EC | Horizon 2020 Framework Programme (No. 848146 (To_Aition))
- License Information
-
More Information
Article History
Received: 23 July 2024
Revised: 9 September 2024
Accepted: 12 September 2024
First Online: 17 September 2024
Competing interests
: EL is cofounder and consultant of IFM Therapeutics and Odyssey Therapeutics as well as a cofounder and board member of Dioscure Therapeutics and a Stealth Biotech. FM is a cofounder and consultant of Odyssey Therapeutics. The other authors declare no competing interests.
